186 related articles for article (PubMed ID: 28002966)
21. The interactions and recognition of cyclic peptide mimetics of Tat with HIV-1 TAR RNA: a molecular dynamics simulation study.
Li CH; Zuo ZC; Su JG; Xu XJ; Wang CX
J Biomol Struct Dyn; 2013 Mar; 31(3):276-87. PubMed ID: 22943434
[TBL] [Abstract][Full Text] [Related]
22. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
[TBL] [Abstract][Full Text] [Related]
23. Solid-phase synthesis and evaluation of TAR RNA targeted beta-carboline-nucleoside conjugates.
Zhao P; Jin HW; Yang ZJ; Zhang LR; Zhang LH
Org Biomol Chem; 2008 Oct; 6(20):3741-50. PubMed ID: 18843404
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of HIV-1 replication in viral mutants with altered TAR RNA stem structures.
Rounseville MP; Lin HC; Agbottah E; Shukla RR; Rabson AB; Kumar A
Virology; 1996 Feb; 216(2):411-7. PubMed ID: 8607271
[TBL] [Abstract][Full Text] [Related]
25. TAR-RNA recognition by a novel cyclic aminoglycoside analogue.
Raghunathan D; Sánchez-Pedregal VM; Junker J; Schwiegk C; Kalesse M; Kirschning A; Carlomagno T
Nucleic Acids Res; 2006; 34(12):3599-608. PubMed ID: 16855296
[TBL] [Abstract][Full Text] [Related]
26. New, extended hairpin form of the TAR-2 RNA domain points to the structural polymorphism at the 5' end of the HIV-2 leader RNA.
Pachulska-Wieczorek K; Purzycka KJ; Adamiak RW
Nucleic Acids Res; 2006; 34(10):2984-97. PubMed ID: 16738137
[TBL] [Abstract][Full Text] [Related]
27. Activation of transcription by HIV-1 Tat protein tethered to nascent RNA through another protein.
Southgate C; Zapp ML; Green MR
Nature; 1990 Jun; 345(6276):640-2. PubMed ID: 2190099
[TBL] [Abstract][Full Text] [Related]
28. Nuclear Factor 90(NF90) targeted to TAR RNA inhibits transcriptional activation of HIV-1.
Agbottah ET; Traviss C; McArdle J; Karki S; St Laurent GC; Kumar A
Retrovirology; 2007 Jun; 4():41. PubMed ID: 17565699
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of HIV-1 TAR RNA-Tat peptide complexation using poly(acrylic acid).
Zhao H; Li J; Jiang L
Biochem Biophys Res Commun; 2004 Jul; 320(1):95-9. PubMed ID: 15207707
[TBL] [Abstract][Full Text] [Related]
30. Nucleobase modified neamines with a lysine as a linker, their inhibition specificity for TAR-Tat derived from HIV-1.
Inoue R; Watanabe K; Katou T; Ikezawa Y; Hamasaki K
Bioorg Med Chem; 2015 May; 23(9):2139-47. PubMed ID: 25819332
[TBL] [Abstract][Full Text] [Related]
31. In vitro selection of RNA aptamers derived from a genomic human library against the TAR RNA element of HIV-1.
Watrin M; Von Pelchrzim F; Dausse E; Schroeder R; Toulmé JJ
Biochemistry; 2009 Jul; 48(26):6278-84. PubMed ID: 19496624
[TBL] [Abstract][Full Text] [Related]
32. Probing the proximity of the core domain of an HIV-1 Tat fragment in a Tat-TAR complex by affinity cleaving.
Huq I; Rana TM
Biochemistry; 1997 Oct; 36(41):12592-9. PubMed ID: 9376365
[TBL] [Abstract][Full Text] [Related]
33. Effect of the position of TAR on transcriptional activation by HIV-1 Tat in vivo.
Wright S; Luccarini C
J Mol Biol; 1996 Oct; 263(1):1-7. PubMed ID: 8890908
[TBL] [Abstract][Full Text] [Related]
34. Thermodynamic studies of a series of homologous HIV-1 TAR RNA ligands reveal that loose binders are stronger Tat competitors than tight ones.
Pascale L; Azoulay S; Di Giorgio A; Zenacker L; Gaysinski M; Clayette P; Patino N
Nucleic Acids Res; 2013 Jun; 41(11):5851-63. PubMed ID: 23605042
[TBL] [Abstract][Full Text] [Related]
35. Tackling Tat.
Karn J
J Mol Biol; 1999 Oct; 293(2):235-54. PubMed ID: 10550206
[TBL] [Abstract][Full Text] [Related]
36. A new class of HIV-1 Tat antagonist acting through Tat-TAR inhibition.
Hamy F; Brondani V; Flörsheimer A; Stark W; Blommers MJ; Klimkait T
Biochemistry; 1998 Apr; 37(15):5086-95. PubMed ID: 9548739
[TBL] [Abstract][Full Text] [Related]
37. Oligonucleotide analogue interference with the HIV-1 Tat protein-TAR RNA interaction.
Arzumanov A; Walsh AP; Liu X; Rajwanshi VK; Wengel J; Gait MJ
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):471-80. PubMed ID: 11563062
[TBL] [Abstract][Full Text] [Related]
38. The binding mode of drugs to the TAR RNA of HIV-1 studied by electric linear dichroism.
Bailly C; Colson P; Houssier C; Hamy F
Nucleic Acids Res; 1996 Apr; 24(8):1460-4. PubMed ID: 8628678
[TBL] [Abstract][Full Text] [Related]
39. Binding of hybrid molecules containing pyrrolo [2,1-c][1,4]benzodiazepine (PBD) and oligopyrrole carriers to the human immunodeficiency type 1 virus TAR-RNA.
Mischiati C; Finotti A; Sereni A; Boschetti S; Baraldi PG; Romagnoli R; Feriotto G; Jeang KT; Bianchi N; Borgatti M; Gambari R
Biochem Pharmacol; 2004 Feb; 67(3):401-10. PubMed ID: 15037192
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of HIV derived lentiviral production by TAR RNA binding domain of TAT protein.
Mi MY; Zhang J; He Y
Retrovirology; 2005 Nov; 2():71. PubMed ID: 16293193
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
